Navigation Links
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Date:1/18/2008

First and only medication approved to reduce both A1C and LDL cholesterol

PARSIPPANY, N.J., Jan. 18 /PRNewswire/ -- Daiichi Sankyo, Inc., announced today that the United States Food and Drug Administration (FDA) has approved Welchol(TM) (colesevelam HCl) to improve glycemic control (measured as hemoglobin A1C) in adults with type 2 diabetes mellitus in combination with metformin, sulfonylureas, or insulin, either alone or in combination with other anti-diabetic agents. Welchol is now the first and only medication approved to reduce both glucose levels and low density lipoprotein cholesterol levels (LDL-C). The ADA estimates that 20.8 million people in the United States have diabetes with more than 90 percent of these people having type 2 diabetes.(1) Forty percent of patients with type 2 diabetes also have high LDL-cholesterol.(2) Welchol is a new option that addresses both these chronic health conditions and provides physicians with a unique therapeutic approach for treating patients with type 2 diabetes.

Pivotal data presented at the American Diabetes Association's (ADA) 67th Annual Scientific Sessions in Chicago in June, 2007 demonstrated that Welchol can lower both A1C and LDL-C levels in patients with type 2 diabetes who were uncontrolled on a metformin-based regimen. Patients in the study were randomly assigned to two groups. The addition of Welchol was compared to the addition of placebo in patients on a metformin-based regimen. The addition of Welchol (n=79) to pre-existing metformin monotherapy achieved a significant mean reduction in A1C levels of 0.47 percent relative to placebo (p<0.0024). Further, the total Welchol treatment group, when treated with either metformin monotherapy or metformin-combination therapy, achieved significantly greater reductions in A1C levels compared to placebo (mean reduction of 0.54%, p<0.001). The study further demonstrated that the total Welchol treatment group achieved significantly lower LDL-C levels comp
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
2. Novadaqs SPY System receives clearance for use in organ transplant surgery
3. BeneChills RhinoChill System Receives CE Marking for European Commercial Sale
4. e-Health Card Terminal From SCM Microsystems Receives GEMATIK Certification
5. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
6. LifeMasters Receives Full URAC Disease Management Accreditation
7. Federal Government Receives Failing Grades on Tobacco Control in Annual American Lung Association Report
8. Glory Foods Receives Heart Healthy Certification
9. TeamStaff Receives Nasdaq Determination Letter
10. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
11. Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique pastries ... wedding cakes with custom designs, making life just a little bit sweeter for ... cakes for each customer who orders one. , The bakery provides a full line ...
(Date:7/31/2015)... ... 31, 2015 , ... Cosmetic Town has proven itself as ... plastic surgery procedures including, but not limited to, abdominoplasty, blepharoplasty, rhinoplasty and septoplasty. ... and fillers. , Staying up to date with the latest cosmetic trends ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 New ... and family members, medical professionals, and researchers, covering a variety of topics related ... a collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan Kettering ...
(Date:7/31/2015)... ... 2015 , ... Creating one of the most modern fertility centers in the ... that goes beyond the boundaries of fertility medicine. , As the leading gynecology ... dependable patient support, affordable treatments, unending hope, and high fertility success rates — all ...
(Date:7/31/2015)... ... ... Girl Scouts of Historic Georgia and Peach State Health Plan are teaming up ... First" program. Representatives from Peach State Health Plan presented a $10,000 check for the ... parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. We are very proud ...
Breaking Medicine News(10 mins):Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... , , , , ... ABT ) today announced financial results for the second quarter ended June ... Diluted earnings per share, excluding specified items, were $0.89, at the high end of ... Accepted Accounting Principles (GAAP) were $0.83. , Worldwide operational ...
... , , LOS ANGELES, July 15 ... get the best possible results with Face Lift Dentistry, a breakthrough ... health and optimal appearance of the mouth and face. , ... DDS, MAGD, long renowned for his high tech cosmetic and bite ...
... ... , ... July 15, 2009 -- HCC Medical Insurance Services is pleased to announce that ... as HCC Medical Insurance Services (HCCMIS), bringing increased financial security to the Company,s portfolio ...
... , LONDON, July 15 realbuzz.com is ... live a healthy, active life and,we,ve been looking at the most ... shorts and head off for your annual summer,holiday, take a peek ... work, and which ones are a total waste of your holiday-prepping,time! ...
... ... featured expert on searchjointpain.com, a new informational Web site devoted to all aspects of ... ... Sinatra , a board-certified cardiologist, nutritionist, and anti-aging specialist, is now a featured expert ...
... , , , SAN ... from the planned spinoff of Cardinal Health,s clinical and medical products businesses, ... principal amount of senior unsecured notes. The notes consist of the ... $250 million aggregate principal amount of 4.125% senior notes due ...
Cached Medicine News:Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 2Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 3Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 4Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 5Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 6Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 7Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 8Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 9Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 10Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 11Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 12Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 13Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 14Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 15Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 16Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 17Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 18Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 19Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 20Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 21Health News:Los Angeles Cosmetic Dentist Sam Muslin's Breakthrough Procedure: Face Lift Dentistry 2Health News:Los Angeles Cosmetic Dentist Sam Muslin's Breakthrough Procedure: Face Lift Dentistry 3Health News:Los Angeles Cosmetic Dentist Sam Muslin's Breakthrough Procedure: Face Lift Dentistry 4Health News:MultiNational Underwriters Is Now HCC Medical Insurance Services 2Health News:realbuzz.com Top 10 Diets 2Health News:realbuzz.com Top 10 Diets 3Health News:realbuzz.com Top 10 Diets 4Health News:Board-Certified Cardiologist Dr. Stephen Sinatra Featured on Searchjointpain.com 2Health News:CareFusion Prices $1.4 Billion of Senior Notes 2
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 /PRNewswire/ ... Novartis /Alcon executives have recently contacted the Company ... will begin as early as Monday, August 3, ... been quoted as saying that the coming electronic ... billions of dollars over the next several years.  ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today ... 2015. Key results include: , Total revenues ... 2014 to $5,370 million, with 6 percent product ... (etanercept), Prolia ® (denosumab), Sensipar ® ... (denosumab). Unfavorable changes in foreign exchange rates ...
(Date:7/30/2015)... Ohio , July 30, 2015  Cleveland Clinic ... OMTEC® 2015 keynote address last month that industry is ... in order to gain the efficiencies—and develop the transformational ... Dr. Barsoum,s comments were preceded by Doug ... entrepreneur and OMTEC moderator, who stressed that industry must ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... Jan. 28, 2011 DARA BioSciences, Inc. (NasdaqCM: ... therapeutic candidates and develops them through proof of ... to larger pharmaceutical companies, announced today that Richard ... February 3, 2011TIME: , 5:00 PM ESTLINK: ...
... Innovations, Inc. (Nasdaq: YDNT ) today announced that ... live and on-demand web cast conference call on Thursday, February ... broadcast of the call will be available through InterCall at ... also be available through the Company,s website, www.ydnt.com . ...
Cached Medicine Technology:DARA BioSciences to Present Live at RetailInvestorConferences.com on February 3 2DARA BioSciences to Present Live at RetailInvestorConferences.com on February 3 3Young Innovations, Inc. Provides 4th Quarter Conference Call Details 2
... whole blood hematology control manufactured specifically for ... and the Coulter AcT5diff instruments. The composition ... cell differential, positioning the populations within the ... The product offers 105-day closed-vial stability and ...
... blood control for evaluating the accuracy and ... blood cell counts in patient body fluid ... WBC values for the Abbott CELL-DYN 3200, ... (levels 2 and 3 only) and Sysmex ...
... is a gene expression ... the risk of metastasis ... It is based on ... the Netherlands Cancer Institute ...
... The Pilot® thoracolumbar pedicle ... to deliver implants safely and ... instrumenting through an open procedure ... the unique screw insertion instrumentation ...
Medicine Products: